The instrument uses reverse hybridization assay for qualitative virus sub-types analysis. When test specimens are added to the slot, it automatically introduces reagents into the Chip slot, extracts DNA, and amplifies PCR via micro-pumps. Amplified products transfer to the Chip test area, undergoing reverse hybridization with probes for virus sub-types. If target gene products are present, they're captured by Chip probes; enzyme reactions produce spots, indicating virus sub-type. Negative specimens show no probe spots.

Founded in 2001, our group is a high-tech biomedical enterprise incorporating R&D, production, sales, and after-sales. We operate a 40,000-square-meter R&D center and have been publicly listed since May 2012. We excel in R&D with a strong team, innovating platforms like molecular diagnosis, immunoassay, atomic absorption, and mass spectrometry.

Our automated nucleic acid tests, a 'lab on a chip', serve diverse medical institutions globally. Through continuous innovation, we enhance mass spectrometry analysis in life sciences, delivering exceptional products and user experience.